International Marijuana Business News – Europe
Major Canadian cannabis producers Hexo and Tilray Brands signed a definitive agreement for a “strategic alliance,” with Tilray acquiring Hexo debt in exchange for the right to purchase Hexo shares.
A pilot program to allow the limited cultivation and distribution of recreational cannabis in the Netherlands has been hit with another major delay.
Despite the success of adult-use marijuana, 2022 is looking like the year pharmaceutical cannabis becomes a major market driver.
Two Canadian medical cannabis producers received European Union-Good Manufacturing Practice (GMP) certification, an essential step to exporting cannabinoids to fast-growing EU markets.
The Kanabo Group is banking on potential growth to correct its stock trend, and how to best use scenario planning in lieu of strategic planning.
A Dutch lighting giant signed a definitive agreement to acquire Texas-based Fluence, which provides grow lights to cannabis cultivators and other agricultural companies, for $272 million.
German pharmaceutical manufacturer Dermapharm Holding SE has struck a deal to buy C3 Cannabinoid Compound Co. GmbH from Canadian cannabis producer Canopy Growth.
